baber/WOPTO huggingface dataset:
Patent ES-523797-A0 (ES)
IPC: C07D501/20
Filed: 1983-07-01
Abstract: Antibiotically active penicillins and cephalosporins of the formula <IMAGE>   in which Z is hydrogen or lower alkoxy, n is 1 or 2, Y, in the form of the free acid, is   <IMAGE>  X is -S-, -n-, -SO- or -SO2-, T is an organic radical, hydrogen or halogen, A is hydroxyl, optionally substituted alkyl, a substituted or unsubstituted phenyl ring, an optionally substituted polycyclic aromatic ring, an optionally substituted 5-membered or 6-membered heterocyclic ring with nitrogen, oxygen and/or sulphur as hetero atoms in the ring, or an optionally substituted polycyclic heterocyclic ring, or non-toxic pharmaceutically tolerated salts thereof.
Patent ES-535141-A0 (ES)
IPC: F16J15/18
Filed: 1984-08-14
Abstract: A centrifugal pump comprising a pump housing, seal means for sealing the wall of said pump housing through which the shaft of the propeller extends, and a seal housing for supporting said seal means. Said seal housing is demountably connected to said wall and has a removable wall portion for permitting access to the seal housing.
Patent ES-536820-A0 (ES)
IPC: A61Q5/02
Filed: 1984-10-17
Abstract: In a shampoo composition which comprises an anionic surface active agent and/or an amphoteric surface active agent as a base, the following two ingredients (A) and (B) are further comprised: (A) 0.5 to 10 wt% of an N-acyl-N-methyl-beta-alanine or its salt represented by the formula (I)in which R represents a linear or branched, saturated or unsaturated hydrocarbon group having from 7 to 21 carbon atoms, and M represents hydrogen, alkali metal etc, (B) 0.5 to 20 wt% of one or more of ethylene oxide-added type nonionic surface active agents selected from the group consisting of polyoxyethylene alkyl or alkenyl ethers, polyoxyethylene alkylphenyl ethers, etc.The composition has excellent detergent performance on the oily dirt exhibiting good foamability at the time of shampooing.
Patent ES-555381-A0 (ES)
IPC: F28D7/16
Filed: 1986-05-28
Abstract: Heat exchanger comprising a casing and tubular or plate-type exchange surfaces mounted inside the casing. The exchange surfaces (15) are joined together in the form of at least one module (14) comprising two end plates (16, 17) between which the exchange surfaces (15) are disposed, said plates (16, 17) being mounted slidingly after the style of drawers in rails (8, 9) of the casing (1). Application: particularly in low-temperature recuperative heat exchangers.
Patent FI-834362-A0 (FI)
Inventor: HUANG FU-CHIH
IPC: C07K5/06
Filed: 1983-11-29
Abstract: Compounds of the general formula  <IMAGE>  and their pharmaceutically-acceptable salts, wherein the substituents are as defined herein, having antihypertensive activity.
Patent FI-841684-A0 (FI)
Inventor: FRITSCH ROBERT
IPC: C08L61/34
Filed: 1984-04-27
Abstract: 1. A process for gluing solid wood with an adhesive based on a condensate of phenol, formaldehyde and resorcinol, or on a condensate of melamine, urea, phenol and formaldehyd, and co-used with a polysaccharide, wherein the adhesive and/or hardener mixture contains from 0.01 to 2.0% by weight of a D-galacto-D-mannan or a xanthane.
Patent FI-842418-A0 (FI)
Inventor: STRAZDINS EDWARD
IPC: D21H13/12
Filed: 1984-06-14
Abstract: A process for increasing rate of dewatering in the manufacture of paper from an aqueous furnish which comprises at least 40% by weight of mechanical wood pulp, thermomechanical wood pulp, or mixtures thereof, by addition thereto of an aluminum salt, e.g., alum, and a water-soluble copolymer containing from about 2 to about 30 mole percent repeating units derived from 2-acrylamido-2-methylpropane sulfonic acid, from 0 to about 25 mole percent repeating unit derived from acrylic acid, and from about 45 to about 98 mole percent repeating units derived from acrylamide, while maintaining pH of the furnish in the range of from about 3.5 to about 6.5.
Patent FI-854512-A0 (FI)
Inventor: ROBERTSON ROBERT LEE
IPC: C07D417/12
Filed: 1985-11-15
Abstract: A novel crystalline form of the monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide has been prepared. This novel crystalline form is designated as polymorph I and is useful in therapy as a nonsteroidal antiarthritic agent. Methods for preparing this polymorph from readily available materials are provided.
Patent FI-862252-A0 (FI)
Inventor: LOMBARDINO JOSEPH GEORGE
IPC: C07D295/14
Filed: 1986-05-28
Abstract: A compound of the formula:- 
<CHEM>
 or a pharmaceutically acceptable acid addition salt thereof, wherein
 R is 2-pyridyl, 6-methyl-2-pyridyl, 6-fluoro-2-pyridyl, 6-chloro-2-pyridyl, 5-methyl-3-isoxazolyl or 2-thiazolyl;
 Y is N,N-dialkylamino having up to three carbon atoms in each alkyl moiety, N-methyl-N-benzylamino, N-ethyl-N-benzylamino, N-methyl-N-( beta -phenylethyl)-amino, N-ethyl-N-( beta -phenylethyl)amino, N-methyl-N-cycloalkylamino and N-ethyl-N-cycloalkylamino each having up to six carbon atoms in the cycloalkyl moiety, N-methyl-N- phenylamino, N-ethyl-N-phenylamino, N-methyl-N- (p-chlorophenyl)amino, N-ethyl-N- (p-chlorophenyl) amino, N-methyl-N- (N min ,N min -dimethylcarbamylmethyl) amino, N-methyl-N- (N min ,N min -diethylcarbamylmethyl) -amino, pyrrolidino, piperidino, 2-methylpiperidino, 2-ethylpiperidino, homopiperidino, 1-azacyclooctyl, N-methylpiperazino, morpholino or thiomorpholino;
 Z is pyridinium, 2-methylpyridinium, 3-methylpyridinium, 4-methylpyridinium, 2,6-dimethylpyridinium, 2,4,6-trimethylpyridinium, 3-ethylpyridinium, 4-ethylpyridinium, 3-ethyl-4-methylpyridinium, 4-ethyl-2-methyl-pyridinium or 5-ethyl-2-methylpyridinium; and
 A is pharmacologically acceptable anion. 
<??>The compounds are anti-inflammatory agents.
Patent FI-885166-A0 (FI)
Inventor: EPPERLY WILLIAM ROBERT
IPC: B01D53/00
Filed: 1988-11-10
Abstract: A process is presented for the reduction of nitrogen oxides in the effluent from the combustion of a carbonaceous fuel. The process comprises injecting a treatment agent comprising sugar into an effluent under conditions effective to reduce the concentration of nitrogen oxides in the effluent.
Patent FI-885847-A0 (FI)
Inventor: HESELIUS LARS
IPC: E04C2/292
Filed: 1988-12-16
Abstract: PCT No. PCT/FI89/00235 Sec. 371 Date Aug. 16, 1991 Sec. 102(e) Date Aug. 16, 1991 PCT Filed Dec. 15, 1989 PCT Pub. No. WO90/07040 PCT Pub. Date Jun. 28, 1990.A longitudinal laminate board of mineral wool and method of making the board are disclosed. The laminate board consists of adjacently disposed pieces at least some of which are shorter than the length of the board and whose fibre plane form an essentially right angle to the plane of the laminate board. The pieces are jointed within the laminate board.
Patent FI-894580-A0 (FI)
Inventor: ARIMA TERUKATSU
IPC: C12Q1/70
Filed: 1989-09-27
Abstract: Disclosed is a non-A, non-B hepatitis virus antigen peptide which exhibits antigen-antibody reaction specificity with at least one of sera from convalescent patient having acute non-A, non-B hepatitis and sera from a patient having chronic non-A, non-B hepatitis. By the use of the antigen peptide of the present invention, not only the diagnosis of non-A, non-B hepatitis but also the screening of blood for transfusion can be achieved with ease and high reliability. The antigen peptide of the present invention may also be used as the basis for a vaccine against non-A, non-B hepatitis.
Patent FI-904497-A0 (FI)
Inventor: KRAMER WERNER
IPC: A61K38/00
Filed: 1990-09-12
Abstract: Bile acid derivatives of the formula I  W-X-G in which G is a bile acid residue, W is an active substance portion of a medicament and X is a linker between bile acid residue and active substance portion, are outstandingly suitable for introducing active substances into the enterohepatic circulation. The compounds I are absorbed and enter the bloodstream. This makes it possible by utilising the natural reabsorption of the bile acids to improve the absorption of drugs which are absorbed with difficulty, if at all. W can be, for example, a peptide, an antibiotic, an antiviral substance, an anticancer agent, a liver protective, an antihyperlipidaemic, a diuretic, an agent to lower blood pressure, a renin inhibitor, a substance to treat cirrhosis of the liver or a substance for treating diabetes. G is a bile acid residue in the form of the free, natural or chemically modified acids, the esters and amides, the salt forms and forms derivatised on alcohol groups. X is a large number of intermediate members or else a bond.
Patent FI-906047-A0 (FI)
IPC: C03B37/05
Filed: 1990-12-07
Abstract: The invention relates to a method for contolling fibre generation in the manufacture of fibres from mineral melt using several cooperating rotating wheels within a defibration unit. The melt route over the wheels is controlled by changing the position of one or more of the rotating wheels (1-4) within a defibration unit on the basis of the various factors affecting defibration process. The control may take place in such a manner that all rotating wheels are turned as a rigid entity around an axle parallel with the rotating wheel axles. Alternatively, one or more wheels are controlled individually in relation to each other. All position changes are essentially executed within the rotation level of the wheels. The invention also relates to the device used for implementing the method.
Patent FI-923263-A0 (FI)
Inventor: ELSAESSER AXEL
IPC: G11B19/20
Filed: 1992-07-16
Abstract: The arrangement eliminates radial and axial play in a spindle (A) on which a disc (S, RM) sits and that is guided by a fixed retainer (F,P). The materials from which the disc and the retainer are made allow a magnetic tone to act between these two components. A segment (K) of a circle is arranged on the retainer next to the disc. A magnetic tone acts between the segment and the disc. The spindle's bearing (M) is fixed to a flange (F) which is in turn fixed to a casing (G). The flange has a ring magnet (RM) through which the spindle passes. The said segment is located next to the disc on the flange. The flange and the segment are metal.
Patent FI-923482-A0 (FI)
Inventor: OLSSON LARS-INGE
IPC: C04B24/30
Filed: 1992-07-31
Abstract: PCT No. PCT/SE91/00096 Sec. 371 Date Aug. 6, 1992 Sec. 102(e) Date Aug. 6, 1992 PCT Filed Feb. 12, 1991 PCT Pub. No. WO91/12214 PCT Pub. Date Aug. 22, 1991.The invention relates to a flowability improving agent comprising a combination, calculated on a dry product, of: A) 60-99% by weight of a sulphonated melamine-formaldehyde resin, a sulphonated melamine-urea-formaldehyde resin or a sulphonated naphthalene-formaldehyde resin; C) 0.5-40% by weight of a boron containing polyhydroxycarboxylic acid or a water-soluble salt of such an acid and optionally D) 0.5-30% by weight of a compound with formula Ar O-(R1)n-R2 where Ar is unsubstituted or substituted benzene moiety or naphthalene moiety, R1 is an oxyethylene group; -CH2CH2O-or an oxypropylene group;   <IMAGE>   an oxyethylene chain or an oxypropylene chain with up to fifteen oxyethylene groups or oxypropylene groups or a combination of oxyethylene groups and oxypropylene groups to a chain where the sum of these groups is at most fifteen; the mean value  &upbar& n for n is 1-15 and R2 is hydrogen or a phosphonate group with the formula   <IMAGE>   where M1 and M2 are hydrogen ion or alkali metal ion or where R2 is a group with the formula   <IMAGE>   where M2 has the above meaning and M3 is -(R1)n-O Ar where R1, n and Ar have the above meaning; a process for the production of the agent and the use of the agent in a cement containing composition.
Patent FI-925947-A0 (FI)
Inventor: DUNLAP RICHARD PAUL
IPC: A61P11/00
Filed: 1992-12-30
Abstract: 4-R<4>-R<5>-2-Saccharinylmethyl heterocyclic carboxylates, having the formula: <CHEM>  wherein: Het is a 5- or 6-membered monocyclic heterocycle or a 9- or 10-membered bicyclic heterocycle containing from 1 to 2 heteroatoms selected from oxygen, nitrogen and sulfur or said heterocycles substituted by from one to three, the same or different, members of the group consisting of lower-alkyl, perfluorolower-alkyl, lower-alkoxy, oxo, phenyl, halogen, and -O-(C2-C10 alkylene)-N=B where N=B is dilower-alkylamino, 1-pyrrolidinyl, 1-piperidinyl, 4-morpholinyl, 1-piperazinyl, or 4-lower-alkyl-1-piperazinyl; R<4> is hydrogen, halogen , lower-alkyl, perfluorolower-alkyl, perchlorolower-alkyl, lower-alkenyl, lower-alkynyl, cyano, carboxamido, amino, lower-alkylamino, dilower-alkylamino, lower-alkoxy, benzyloxy, lower-alkoxycarbonyl, hydroxy or phenyl; and R<5> is hydrogen or from one to two substituents in any of the 5-, 6- or 7-positions. The compounds of the present invention inhibit the activity of serine proteases, specifically human leukocyte elastase and the chymotrypsin-like enzymes, and are thus useful in the treatment of degenerative disease conditions such as emohysema, rheumatoid arthritis, pancreatitis, cystic fibrosis, chronic bronchitis, adult respiratory distress syndrome, inflammatory bowel disease, psoriasis, bullous pemphigoid and alpha-1-antitrypsin deficiency.
Patent FI-930799-A0 (FI)
Inventor: JEPPESEN LONE
IPC: C07D321/10
Filed: 1993-02-23
Abstract: Piperazinyl derivatives of the general formula I   <IMAGE> (I) wherein R1 represents substituted phenyl, 1- or 2-diazanaphthyl, azadiazanaphtyl or diazanaphtyl groups; n is 1, 2, 3 or 4; X is -O- or  <IMAGE>   wherein R2 is hydrogen, C1-6-alkyl or C3-8-cycloalkyl; Y is =O or =S or =NZ wherein Z is hydrogen, C1-6-alkyl or -CN and R3 is selected from a group consisting of various structures have been found to exhibit high affinity for various receptor subtypes including the 5-HT2 receptor, the 5-HT1A receptor, the alpha1 receptor the dopamine receptor or a combination of these and may therefore be useful for treating CNS system, cardiovascular system and gastrointestinal disorders.
Patent FI-941580-A0 (FI)
Inventor: SCHNUR RODNEY C
IPC: C07D487/08
Filed: 1994-04-06
Abstract: This invention relates to compounds of the formuladefined below. Such compounds are useful as oncogene inhibitors and antitumor agents.
Patent FI-970680-A0 (FI)
Inventor: LIDDELL JOHN MACDONALD
IPC: C08G63/06
Filed: 1997-02-18
Abstract: PCT No. PCT/GB95/01926 Sec. 371 Date Jun. 16, 1997 Sec. 102(e) Date Jun. 16, 1997 PCT Filed Aug. 15, 1995 PCT Pub. No. WO96/06179 PCT Pub. Date Feb. 29, 1996A hydroxyalkanoic acid (PHA)is recovered from matter derived from living organisms by dissolving the PHA in a solvent which is a lower ketone, dialkyl ether or a lower alcohol or a monocarboxylic acid ester thereof, separating the solution from such matter and recovering PHA from the solution.
Patent FI-973102-A0 (FI)
Inventor: SCHWERTFEGER FRITZ
IPC: C01B33/16
Filed: 1997-07-24
Abstract: PCT No. PCT/EP96/00308 Sec. 371 Date Jul. 24, 1997 Sec. 102(e) Date Jul. 24, 1997 PCT Filed Jan. 26, 1996 PCT Pub. No. WO96/22942 PCT Pub. Date Aug. 1, 1996The invention relates to a process for the production of modified SiO2 aerogels in which a) a silicatic lyogel is prepared, b) if desired, the lyogel prepared in step a) is subjected to a solvent exchange with another organic solvent, c) the gel obtained in step a) or b) is reacted with at least one chlorine-free silylating agent, and d) the gel obtained in step c) is dried subcritically, wherein the chlorine-free silylating agent is a compound of the formula I    <IMAGE>  (I)   wherein each R1 is identical or different and is selected from a group consisting of linear C1-C6-alkyl radicals, branched C1-C6-alkyl radicals, cyclohexyl radicals and phenyl radicals, R2, R3 and R4 are identical or different and are selected from the group consisting of hydrogen atoms, linear C1-C6-alkyl radicals, branched C1-C6-alkyl radicals, cyclohexyl radicals and phenyl radicals; and n=1, 2 or 3.
Patent FI-981818-A0 (FI)
Inventor: LINDHOLM SAM T
IPC: A61L/
Filed: 1998-08-25
Abstract: The present invention is related to an osteogenic device and its preparation. Said device comprises a bone morphogenetic protein (BMP), preferably a modified BMP complex obtainable by a modification of the conventional guanidum hydrochloride extraction method and collagens, preferably collagen I or collagen IV, impregnated in and/or adsorbed on a bioceramic carrier, preferably a shapable body (block) originating from a coral skeleton. The method of isolating said modified BMP complex which lacks an immunogenic component and consists essentially of a 100-700 kD and a 15-25 kD protein with osteoinductive properties and preferably of the 15-25 kD protein which has improved storage properties as well as its use in the osteogenic device with improved osteoinductive properties is also disclosed.
Patent FI-982009-A0 (FI)
Inventor: HAYNES DUNCAN H
IPC: A61P23/00
Filed: 1998-09-17
Abstract: The following are claimed: (A) microdroplet (200 Å to 1 mu m in diameter) comprising a sphere of propofol surrounded by a stabilising layer of a phospholipid and devoid of oils capable of supporting bacterial growth. (B) anti-microbial pharmaceutical composition, comprising: (a) microdroplets (of 200 Å to 1 mu m in diameter), produced by sonification, homogenisation, microfluidisation or other processes, and comprising a propofol core stabilised against coalescence and surrounded by a phospholipid membrane layer (PML); and (b) an injectable carrier. The ratio of the volume of propofol to the weight of the PML is at least 1.0 ml/g. The composition is devoid of fats and triglycerides and contains at least 3 % (weight/volume) of propofol.
Patent AP-9801338-A0 (AP)
Title: Convesion of sewage sludge to humus.
Inventor: PABSCH JOACHIM
IPC: C02F11/00
Filed: 1998-01-07
Abstract: The invention pertains to a method for processing sewage sludge into humus through a complete stuffing cycle, consisting in charging in a first cycle a first poler with sewage sludge up to a set height. Then, the water contents of the liquid sewage sludge is reduced, preferably by draining the first polder and by sowing fine-rooted rapid-growing plants, including psture grass. The plants in the first polder then enter a growth period, the end of which means the end of the first cycle. Several polders may so be used with a time-shift. The duration of a cycle is approximately 12 months.
Patent IL-58445-A0 (IL)
Title: -azolyl- -phenylacetic acid derivatives their manufacture and their use as fungicides
IPC: C07D231/12
Filed: 1979-10-12
Abstract: New compounds of the formula   <IMAGE>   which have a good fungicidal action, their manufacture, fungicides containing these compounds as active ingredients, and processes for combating fungi with these compounds.
Patent IL-96636-A0 (IL)
Title: Piperidine derivatives and pharmaceutical compositions containing them
IPC: A61K31/451
Filed: 1990-12-11
Abstract: Compounds of the formula IV for use as local anaesthetica and analgetica, as well as a method for their preparation, their pharmaceutical preparations and their use.    <IMAGE>  IV
Patent SE-9201587-A0 (SE)
Inventor: KARANEWSKY DONALD STEVEN
IPC: C07F9/6506
Filed: 1992-05-14
Abstract: N/A
Patent FI-20011215-A0 (FI)
Inventor: NYBERG KAISA
IPC: H04L9/08
Filed: 2001-06-08
Abstract: The invention relates to a method for ensuring data transmission security between a first (2) and a second communication device (3) in short-range wireless communication. To set up a secure data transmission connection, the communication devices (2, 3) conduct a key exchange stage to generate at least one shared key (K) between the communication devices. After said key exchange stage at least a first (c1) and a second check string (c2) is formed, said strings being based at least on a unique short random string and on the keys (K1, K2) generated in each communication device at said key exchange stage. Thus, the security of the connection that is set up is ensured by comparing the correspondence of said check strings (c1, c2). The invention also relates to a communication system and a communication device, in which the method will be applied.
Patent FI-20075548-A0 (FI)
Inventor: AHOMAEKI TIMO
IPC: H04L51/00
Filed: 2007-07-17
Abstract: Disclosed is a method and an advertising system for delivering advertisements in a mobile communication network. The method comprises detecting a need to deliver an advertisement to a specific recipient, finding out user specific context information pertaining to said recipient, responsive to the user specific context information so requiring, adjusting at least one aspect pertaining to said advertisement, and delivering said adjusted advertisement to said recipient.
Patent IL-100637-A0 (IL)
Title: Salts of 2-(2,6-dichloroanilino)-phenylacetic acid,a process for their preparation and their use for pharmaceutical preparation to be applied locally
IPC: A61P25/04
Filed: 1992-01-12
Abstract: Novel salts of 2-(2,6-dichloroanilino)phenylacetic acid of the general formula (I) 
<IMAGE>
 in which Me represents a rubidium or caesium atom, and also a process for the preparation of these salts and pharmaceutical preparations containing these salts are described. The novel salts or the pharmaceutical preparations containing the salts can be employed successfully for the treatment of inflammatory and rheumatic processes and pain conditions.
Patent IL-101963-A0 (IL)
Title: Isolated and purified dna sequences coding antigen expressed by tumor cells and recognized by cytotoxic t cells,and uses thereof
IPC: G01N33/53
Filed: 1992-05-22
Abstract: The invention relates to an isolated DNA sequence which codes for an antigen expressed by tumor cells which is recognized by cytotoxic T cells, leading to lysis of the tumor which expresses it. Also described are cells transfected by the DNA sequence, and various therapeutic and diagnostic uses arising out of the properties of the DNA and the antigen for which it codes.
Patent IL-102291-A0 (IL)
Title: Graft copolymers,their preparation and aqueous compositions containing them
IPC: C08F2/22
Filed: 1992-06-24
Abstract: A two stage aqueous emulsion polymerization process for making graft copolymers is described. In the first stage, at least one first ethylenically unsaturated monomer is polymerized in the presence of at least one mercapto-olefin compound to form a macromonomer with terminal functional groups. In the second stage, at least one second ethylenically unsaturated monomer is polymerized in the presence of the macromonomer such that a copolymer is formed with a backbone of polymerized units of the at least one second ethylenically unsaturated monomer and side chains of the macromonomer.
Patent IL-104573-A0 (IL)
Title: Azaindoles,their preparation and pharmaceutical compositions containing them
IPC: A61K31/44
Filed: 1993-02-01
Abstract: These compounds correspond to the formula, <IMAGE>  in which,   one of the groups X1 to X4 represents nitrogen and the others a CH radical, R1 and R2 represent H, halogen, alkyl, hydroxymethyl, alkyloxymethyl, dialkylaminoalkyl, dialkylaminoalkyloxymethyl, carboxyl, ethyl carboxylate, piperidino, alkenyl, cycloalkyl, cycloalkenyl, alkylthio, benzyl, phenyl, thiophene or pyridine, optionally substituted, R3 and R4 represent H, halogen, alkyl, cycloalkyl, alkoxy or alkylthio, R5 and R6 denote H, alkyl, alkenyl, cycloalkyl, cycloalkenyl, alkoxyalkyl, alkylthioalkyl, or together form alkylene or alkyleneoxyalkylene chains, R7 denotes H, alkyl or cycloalkyl, one of the R5 to R7 radicals can also denote optionally substituted phenyl or benzyl, R8 represents H, alkyl, cycloalkyl, phenyl or benzyl, optionally substituted, R9 denotes optionally substituted phenyl, naphthyl or heterocyclyl,   and their tautomeric forms, processes for their preparation and application as hypolipidaemic and anti-atheromatous medicaments.
Patent IL-107349-A0 (IL)
Title: A process for the production of a seasoning sauce based on oat
IPC: A23L23/00
Filed: 1993-10-21
Abstract: A process for the production of a seasoning sauce, which comprises oat grains as the substrate to result in a lighter colored sauce. Additionally, the level of salt present during a multi-step fermentation is controlled using a relatively low salt brine.